News

Aeluma Advances with New Patent in Semiconductor Innovation

Aeluma Advances with New Patent in Semiconductor Innovation

Aeluma's New Patent in Semiconductor Technology

Aeluma, Inc. (NASDAQ: ALMU), a leader in semiconductor technology, has recently taken an exciting step forward by filing a new patent application. This move not only showcases their commitment to innovation but also marks an expansion of their intellectual property portfolio to a total of 35 issued and pending patents.

Breaking Ground in Semiconductor Manufacturing

The latest patent application focuses on the volume manufacturing of compound semiconductor photonics. These advancements are particularly aimed at enhancing applications in mobile devices, consumer electronics, and data center interconnects. Aeluma is building on its existing patents that cover a variety of applications, including 3D imaging sensors crucial for consumer electronics and large-format imagers designed for defense systems.

Harnessing Intellectual Property for Competitive Advantage

By bolstering its patent portfolio, Aeluma is strategically strengthening its proprietary heterogeneous integration platform. This is vital for supporting scalable semiconductor manufacturing and building a competitive moat across various commercial sectors, positioned for mass-market adoption.

Expert Insights on Commercialization Strategy

Dr. Andrew Huntington, Senior Principal Scientist at Aeluma, emphasized the importance of intellectual property development in the company’s journey toward commercialization. He noted, "Building on our disruptive semiconductor technology, we continue to add patent protection as we advance. This isn’t merely an R&D milestone; it is a crucial step in our commercialization strategy, as we engage with customers looking to integrate our technologies into their products."

Strategically Positioned for Success

Aeluma's IP portfolio is carefully structured to protect all stages of the commercialization lifecycle. This includes the integration of compound semiconductor materials on mismatched substrates as well as advanced manufacturing processes and final system integration. The primary target markets for Aeluma encompass mobile technologies, artificial intelligence (AI), and defense industries.

Maintaining Competitive Edge with Trade Secrets

In addition to its robust patent portfolio, Aeluma safeguards valuable trade secrets related to its manufacturing processes. This combination of patents and proprietary knowledge is instrumental as the company focuses on scaling high-performance semiconductors to meet growing global demands.

About Aeluma Inc.

Aeluma (NASDAQ: ALMU) is at the forefront of semiconductor innovation, specializing in high-performance photonic and electronic technologies that can be scaled for mass production. Its proprietary manufacturing platform enables the integration of compound semiconductors into microelectronics, pushing the boundaries of what is possible in various applications such as mobile, AI, defense, aerospace, robotics, automotive, AR/VR, and quantum technologies. Aeluma is based in Goleta, California, where it operates cutting-edge R&D and manufacturing facilities to support semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, testing, and validation.

Getting in Touch with Aeluma

If you wish to learn more about Aeluma's technology or have any inquiries, feel free to contact the company at:

Company:
Aeluma, Inc.
Phone: (805) 351-2707
Email: info@aeluma.com

Investor Contact:

Financial Profiles, Inc.
Moira Conlon and Alex Villalta
(310) 622-8227
Email: ir@aeluma.com

Frequently Asked Questions

What new patent has Aeluma filed?

Aeluma has filed a new patent application that focuses on volume manufacturing of compound semiconductor photonics for various applications.

How many patents does Aeluma currently hold?

The company has expanded its intellectual property portfolio to a total of 35 issued and pending patents.

What are the applications of Aeluma's technology?

Aeluma's technology applications include mobile devices, AI, defense, aerospace, robotics, automotive, AR/VR, and quantum technologies.

What is Dr. Andrew Huntington's role at Aeluma?

Dr. Andrew Huntington is the Senior Principal Scientist, focusing on advancing Aeluma's semiconductor technology.

How can I contact Aeluma for more information?

You can contact Aeluma at info@aeluma.com or call them at (805) 351-2707.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 401

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 659

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 157

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 508

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 499

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 440

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading

Top 5 Most Recently Viewed Articles

Antengene's XPOVIO® Gains Approval in Thailand for Cancer Treatment

Updated Category News Views 114

Antengene's Recent Approval of XPOVIO® in Thailand Antengene Corporation Limited, a distinguished global biopharmaceutical company, has reached a notable achievement with the approval of XPOVIO® (selinexor) by the Thailand Food and Drug Administration. This approval marks XPOVIO® as the first and only XPO1 inhibitor authorized for sale in the Thai market. The drug,...

Continue Reading
Monumental Pediatric Surgery Advances at Nicklaus Children

Updated Category News Views 23

Redefining Pediatric Surgery with Mixed Reality Cue the drumroll, because Nicklaus Children's Hospital in Miami just pulled off a doozy in the medical field. The region's first pediatric total hip replacement using mixed reality-assisted guidance has taken place, and the ripples from this bad boy could be significant. The Hero of the Hour: Dr. Thomas J. Utset-Ward Dr....

Continue Reading
Contrasting Luxury Real Estate Trends in the U.S. Market

Updated Category News Views 151

The Evolving Landscape of U.S. Luxury Real Estate In the world of luxury real estate, change is the only constant. A recent report sheds light on how the U.S. luxury housing market is adapting to buyer preferences, with 2026 marking an interesting phase in pricing stabilization. Nationally, entry-level luxury prices stand steady at $1.19 million, but the interpretation of...

Continue Reading
Bureau Veritas Explores Potential Merger with SGS

Updated Category News Views 325

Exploring Business Synergies: Bureau Veritas and SGS Recent media discussions have shed light on the evolving landscape of Bureau Veritas as it engages in talks with SGS about the possibility of a business merger. This potential union reflects the growing trend within industries to enhance competencies and create greater value through collaboration. Bureau Veritas, a...

Continue Reading
Equifax Engages Investors in September Conferences Overview

Updated Category News Views 133

Equifax Invites Investors to Upcoming Conferences Equifax®, a leading data, analytics, and technology company recognized by its stock symbol EFX on the NYSE, is gearing up to engage with investors through several key conferences this September. This month presents an excellent opportunity for investors to gain insights into the company's strategy and future direction....

Continue Reading